Exosomes: mechanisms of uptake KJ McKelvey, KL Powell, AW Ashton, JM Morris, SA McCracken Journal of circulating biomarkers 4, 7, 2015 | 449 | 2015 |
Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation M Xue, K McKelvey, K Shen, N Minhas, L March, SY Park, CJ Jackson Rheumatology 53 (12), 2270-2279, 2014 | 199 | 2014 |
Radiation, inflammation and the immune response in cancer KJ McKelvey, AL Hudson, M Back, T Eade, CI Diakos Mammalian genome 29 (11), 843-865, 2018 | 158 | 2018 |
Application of mitochondrially targeted nanoconstructs to neoadjuvant x-ray-induced photodynamic therapy for rectal cancer W Deng, KJ McKelvey, A Guller, A Fayzullin, JM Campbell, S Clement, ... ACS central science 6 (5), 715-726, 2020 | 63 | 2020 |
Activated protein C: A regulator of human skin epidermal keratinocyte function K McKelvey, CJ Jackson, M Xue World journal of biological chemistry 5 (2), 169, 2014 | 53 | 2014 |
Cell-specific expression of TLR9 isoforms in inflammation KJ McKelvey, J Highton, PA Hessian Journal of autoimmunity 36 (1), 76-86, 2011 | 46 | 2011 |
Targeting glucose metabolism of cancer cells with dichloroacetate to radiosensitize high-grade gliomas KM Cook, H Shen, KJ McKelvey, HE Gee, E Hau International Journal of Molecular Sciences 22 (14), 7265, 2021 | 35 | 2021 |
Glycolysis and fatty acid oxidation inhibition improves survival in glioblastoma KJ McKelvey, EB Wilson, S Short, AA Melcher, M Biggs, CI Diakos, ... Frontiers in Oncology 11, 633210, 2021 | 32 | 2021 |
Treatment of chronic diabetic lower leg ulcers with activated protein C: a randomised placebo‐controlled, double‐blind pilot clinical trial K Whitmont, KJ McKelvey, G Fulcher, I Reid, L March, M Xue, A Cooper, ... International wound journal 12 (4), 422-427, 2015 | 29 | 2015 |
Potential anti-inflammatory treatments for chronic wounds K McKelvey, M Xue, K Whitmont, K Shen, A Cooper, C Jackson Wound Practice & Research: Journal of the Australian Wound Management …, 2012 | 22 | 2012 |
Are in vitro human blood–brain–tumor-barriers suitable replacements for in vivo models of brain permeability for novel therapeutics? A Prashanth, H Donaghy, SP Stoner, AL Hudson, HR Wheeler, CI Diakos, ... Cancers 13 (5), 955, 2021 | 21 | 2021 |
Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model KJ McKelvey, AL Hudson, R Prasanna Kumar, JS Wilmott, GH Attrill, ... PLoS One 15 (4), e0226444, 2020 | 21 | 2020 |
Activated protein C targets immune cells and rheumatoid synovial fibroblasts to prevent inflammatory arthritis in mice M Xue, S Dervish, KJ McKelvey, L March, F Wang, CB Little, CJ Jackson Rheumatology 58 (10), 1850-1860, 2019 | 21 | 2019 |
Low circulating protein C levels are associated with lower leg ulcers in patients with diabetes K Whitmont, G Fulcher, I Reid, M Xue, K McKelvey, Y Xie, M Aboud, ... BioMed Research International 2013, 2013 | 21 | 2013 |
Aberrant levels of natural IgM antibodies in osteoarthritis and rheumatoid arthritis patients in comparison to healthy controls TG Nguyen, KJ McKelvey, LM March, DJ Hunter, M Xue, CJ Jackson, ... Immunology letters 170, 27-36, 2016 | 20 | 2016 |
NF-κB regulation in maternal immunity during normal and IUGR pregnancies G Ariyakumar, JM Morris, KJ McKelvey, AW Ashton, SA McCracken Scientific reports 11 (1), 20971, 2021 | 18 | 2021 |
The intertwined fates of inflammation and coagulation in glioma A Cho, KJ McKelvey, A Lee, AL Hudson Mammalian genome 29 (11), 806-816, 2018 | 17 | 2018 |
Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblasts SM Julovi, K Shen, K McKelvey, N Minhas, L March, CJ Jackson Molecular Medicine 19, 324-331, 2013 | 15 | 2013 |
Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction M Lappas, S McCracken, K McKelvey, R Lim, J James, CT Roberts, ... MHR: Basic science of reproductive medicine 24 (2), 94-109, 2018 | 14 | 2018 |
Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2 M Xue, K Shen, K McKelvey, J Li, YKA Chan, V Hatzis, L March, CB Little, ... Arthritis research & therapy 16, 1-12, 2014 | 14 | 2014 |